Overshooting the mark: subclinical hyperthyroidism secondary to excess thyroid hormone treatment may be more prevalent than we realise.
Choi
Ah-Rin Anna
AR
Manning
Patrick
P
D006207:Half-Life; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced*; D007037:Hypothyroidism / Q000188:drug therapy; D015995:Prevalence; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
D013972:Thyrotropin; D013974:Thyroxine